GlassScriptPhysician profile
Michael R Dorwart
NPI 1225243892
$2,989.16
in general payments reported to CMS, 2019-2025
16 companies · $1,194 in 2025
The $1,194 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $237 · 2021: $124 · 2022: $115 · 2023: $217 · 2024: $603 · 2025: $1,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,566 · Travel and Lodging: $448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,566.46 |
| Travel and Lodging | $447.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $893.24 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Medtronic USA, INC. | $735.70 | 2019-2020 | |
| Abbott Laboratories | $522.65 | 2025 | Proclaim |
| Abbvie INC. | $195.90 | 2025 | |
| Boston Scientific Corporation | $185.79 | 2024 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $151.02 | 2023 | Senza |
| Saluda Medical Americas, INC. | $66.31 | 2025 | Evoke |
| Spr Therapeutics, INC | $47.60 | 2022 | |
| Biotronik Nro, INC. | $42.95 | 2025 | Prospera |
| Painteq LLC | $34.59 | 2024 | Painteq |
| Tersera Therapeutics LLC | $25.99 | 2025 | Prialt |
| Tonix Medicines, INC. | $21.48 | 2025 | Tonmya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.36 | 2025 | Relistor |
| Collegium Pharmaceutical, INC. | $19.83 | 2025 | Xtampza |
| Pacira Pharmaceuticals Incorporated | $18.00 | 2024 | Exparel |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $7.75 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dorwart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.